Idexx Laboratories Inc /De financial data

Symbol
IDXX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
One Idexx Drive, Westbrook, Maine
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 148 % +44.2%
Quick Ratio 38.7 % +12.1%
Debt-to-equity 121 % -54.5%
Return On Equity 125 % +21.1%
Return On Assets 25.8 % -9.86%
Operating Margin 28.6 % -4.02%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.3M shares -0.85%
Common Stock, Shares, Outstanding 82.5M shares -0.7%
Entity Public Float 41.3B USD +42.7%
Common Stock, Value, Issued 10.8M USD +0.29%
Weighted Average Number of Shares Outstanding, Basic 82.6M shares -0.55%
Weighted Average Number of Shares Outstanding, Diluted 83.4M shares -0.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.78B USD +7.71%
Cost of Revenue 1.5B USD +6.52%
Research and Development Expense 208M USD +13.8%
Selling and Marketing Expense 570M USD +3.55%
General and Administrative Expense 425M USD +30.2%
Operating Income (Loss) 1.08B USD +3.38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.06B USD +6.1%
Income Tax Expense (Benefit) 216M USD +3.29%
Net Income (Loss) Attributable to Parent 846M USD +6.85%
Earnings Per Share, Basic 10.2 USD/shares +6.93%
Earnings Per Share, Diluted 10.1 USD/shares +7.11%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 402M USD +202%
Accounts Receivable, after Allowance for Credit Loss, Current 534M USD +15.5%
Inventory, Net 380M USD -3.84%
Other Assets, Current 213M USD +12.8%
Assets, Current 1.53B USD +29.7%
Deferred Income Tax Assets, Net 126M USD +92.9%
Property, Plant and Equipment, Net 708M USD +3.65%
Operating Lease, Right-of-Use Asset 120M USD +4.71%
Intangible Assets, Net (Excluding Goodwill) 111M USD +21.9%
Goodwill 408M USD +12%
Other Assets, Noncurrent 540M USD +22.9%
Assets 3.41B USD +19%
Accounts Payable, Current 117M USD +9.11%
Employee-related Liabilities, Current 124M USD -1.26%
Accrued Liabilities, Current 541M USD +35.5%
Contract with Customer, Liability, Current 38M USD +0.58%
Liabilities, Current 1.12B USD +26.3%
Contract with Customer, Liability, Noncurrent 26.8M USD -7.81%
Accrued Income Taxes, Noncurrent 28.7M USD -32.8%
Deferred Income Tax Liabilities, Net 10M USD +80%
Operating Lease, Liability, Noncurrent 103M USD +5.78%
Other Liabilities, Noncurrent 53.4M USD -16.9%
Liabilities 1.83B USD +3.25%
Accumulated Other Comprehensive Income (Loss), Net of Tax -85.2M USD -15.6%
Retained Earnings (Accumulated Deficit) 4.88B USD +20.9%
Stockholders' Equity Attributable to Parent 1.58B USD +44.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.48B USD +144%
Liabilities and Equity 3.41B USD +19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 199M USD +7.98%
Net Cash Provided by (Used in) Financing Activities -144M USD +1.37%
Net Cash Provided by (Used in) Investing Activities -107M USD -171%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 108M shares +0.29%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -56.5M USD -4692%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 402M USD +202%
Deferred Tax Assets, Valuation Allowance 34.8M USD -12.4%
Deferred Tax Assets, Gross 246M USD +33.9%
Operating Lease, Liability 123M USD +5.12%
Payments to Acquire Property, Plant, and Equipment 30.3M USD -23.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 834M USD +6.19%
Lessee, Operating Lease, Liability, to be Paid 145M USD +4.55%
Property, Plant and Equipment, Gross 1.49B USD +9.71%
Operating Lease, Liability, Current 20.1M USD +1.84%
Lessee, Operating Lease, Liability, to be Paid, Year Two 24.4M USD +20.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 26.3M USD +9.15%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -2.57M USD +31.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.9M USD +1.44%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.6M USD +13%
Deferred Tax Assets, Operating Loss Carryforwards 9.01M USD +0.57%
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 22.3M USD -1.01%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.9M USD +5.8%
Operating Lease, Payments 7.16M USD -7.97%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 29.9M USD +5.55%
Deferred Tax Assets, Net of Valuation Allowance 212M USD +46.6%
Share-based Payment Arrangement, Expense 60.5M USD +8.94%
Interest Expense 36.4M USD -20.9%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%